Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP4904517B2 - Method for producing racemic piperidine derivatives - Google Patents
[go: Go Back, main page]

JP4904517B2 - Method for producing racemic piperidine derivatives - Google Patents

Method for producing racemic piperidine derivatives Download PDF

Info

Publication number
JP4904517B2
JP4904517B2 JP2001279111A JP2001279111A JP4904517B2 JP 4904517 B2 JP4904517 B2 JP 4904517B2 JP 2001279111 A JP2001279111 A JP 2001279111A JP 2001279111 A JP2001279111 A JP 2001279111A JP 4904517 B2 JP4904517 B2 JP 4904517B2
Authority
JP
Japan
Prior art keywords
group
piperidine derivative
phenyl
optically active
racemic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2001279111A
Other languages
Japanese (ja)
Other versions
JP2002234873A (en
Inventor
年弘 藤野
治代 佐藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Fine Chemicals Co Ltd
Original Assignee
Toray Fine Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Fine Chemicals Co Ltd filed Critical Toray Fine Chemicals Co Ltd
Priority to JP2001279111A priority Critical patent/JP4904517B2/en
Publication of JP2002234873A publication Critical patent/JP2002234873A/en
Application granted granted Critical
Publication of JP4904517B2 publication Critical patent/JP4904517B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【0001】
【発明の属する技術分野】
本発明は、医薬あるいはその中間体として有用な一般式(1)、一般式(2)、一般式(3)
【0002】
【化4】

Figure 0004904517
【0003】
(R1は炭素数1〜4の低級アルキル基、フェニル基、およびアラルキル基を示し、R2、R3、R4は同じであっても異なっていてもよく、水素、アルキル基、フェニル基、アラルキル基、アルコキシカルボニル基、アルキルスルホニル基、アリルスルホニル基、アラルキルスルホニル基、およびアシル基を示し、R5はアルキル基、フェニル基、アラルキル基、アルコキシカルボニル基、アルキルスルホニル基、アリルスルホニル基、アラルキルスルホニル基、およびアシル基を示す。)で表される光学活性ピペリジン誘導体を、光学分割によって製造する際に副生する不要の光学対掌体をラセミ化することによる、ラセミピペリジン誘導体の製造法を提供することにある。特に式(6)
【0004】
【化5】
Figure 0004904517
【0005】
で表される光学活性3−[3−(メチルスルフォニル)フェニル]−1−プロピルピペリジンはパーキンソン病薬として有用な化合物である。
【0006】
【従来の技術】
光学活性なピペリジン誘導体を得るためにはそのラセミ体を光学分割すれば良いが、その収率は理論的にはラセミ体の50%であり工業的製造法としては不十分である。そこで不要な光学対掌体をラセミ化して光学分割の原料としてリサイクルできれば、光学活性ピペリジン誘導体は理論的には100%に近い収率で生産できることになる。従って、光学活性ピペリジン誘導体をラセミ化させることによるラセミピペリジン誘導体の製造法は重要な技術と言える。しかし、一般式(1)、一般式(2)、一般式(3)
【0007】
【化6】
Figure 0004904517
【0008】
(R1は炭素数1〜4の低級アルキル基、フェニル基、およびアラルキル基を示し、R2、R3、R4は同じであっても異なっていてもよく、水素、アルキル基、フェニル基、アラルキル基、アルコキシカルボニル基、アルキルスルホニル基、アリルスルホニル基、アラルキルスルホニル基、およびアシル基を示し、R5はアルキル基、フェニル基、アラルキル基、アルコキシカルボニル基、アルキルスルホニル基、アリルスルホニル基、アラルキルスルホニル基、およびアシル基を示す。)で表される光学活性ピペリジン誘導体をラセミ化する方法は全く知られていない。
【0009】
【発明が解決しようとする課題】
前述のように、ラセミピペリジン誘導体を光学分割して、所望の光学活性ピペリジン誘導体を製造する際には、もう一方の不要な光学対掌体が生成する。従って、所望の光学活性ピペリジン誘導体を収率良く製造するために、光学活性ピペリジン誘導体をラセミ化する方法が望まれていた。
【0010】
【課題を解決するための手段】
本発明者らはラセミピペリジン誘導体の工業的に実施可能な製造法を鋭意検討した結果、この目的は光学活性ピペリジン誘導体を水素加圧下で還元触媒存在下に反応させることにより達成されることが判った。
【0011】
すなわち、本発明は、一般式(1)、一般式(2)、一般式(3)
【0012】
【化7】
Figure 0004904517
【0013】
(R1は炭素数1〜4の低級アルキル基、フェニル基、およびアラルキル基を示し、R2、R3、R4は同じであっても異なっていてもよく、水素、アルキル基、フェニル基、アラルキル基、アルコキシカルボニル基、アルキルスルホニル基、アリルスルホニル基、アラルキルスルホニル基、およびアシル基を示し、R5はアルキル基、フェニル基、アラルキル基、アルコキシカルボニル基、アルキルスルホニル基、アリルスルホニル基、アラルキルスルホニル基、およびアシル基を示す。)
のいずれかで表される光学活性ピペリジン誘導体を、還元触媒存在下に水素雰囲気中で反応させることを特徴とするラセミピペリジン誘導体の製造方法である。
【0014】
【発明の実施の形態】
ここで、本発明において出発物質として用いられる光学活性ピペリジン誘導体としては次の一般式(1)、一般式(2)、一般式(3)
【0015】
【化8】
Figure 0004904517
【0016】
(R1は炭素数1〜4の低級アルキル基、フェニル基、およびアラルキル基を示し、R2、R3、R4は同じであっても異なっていてもよく、水素、アルキル基、フェニル基、アラルキル基、アルコキシカルボニル基、アルキルスルホニル基、アリルスルホニル基、アラルキルスルホニル基、およびアシル基を示し、R5はアルキル基、フェニル基、アラルキル基、アルコキシカルボニル基、アルキルスルホニル基、アリルスルホニル基、アラルキルスルホニル基、およびアシル基を示す。)のいずれかで表される光学活性ピペリジン誘導体が使用できる。なかでも一般式(1)で表される光学活性ピペリジン誘導体をラセミ化する際に好ましく適用できる。
【0017】
さらに、光学活性ピペリジン誘導体が式(4)または(5)
【0018】
【化9】
Figure 0004904517
【0019】
(R1は炭素数1〜4の低級アルキル基、R4は炭素数1〜4のアルキルスルホニル基を示す。)
で示されるものである場合に好ましく適用できる。
【0020】
特に式(6)
【0021】
【化10】
Figure 0004904517
【0022】
で表されるラセミ3−[3−(メチルスルフォニル)フェニル]−1−プロピルピペリジンを製造する際に有用である。
【0023】
ここで光学活性ピペリジン誘導体とは、一方の光学異性体が他方の光学異性体より多く含有されるピペリジン誘導体を意味し、実質的には光学純度が30%e.e.以上のピペリジン誘導体を意味する。
【0024】
また、ラセミピペリジン誘導体とは、原料よりも光学純度が低下したピペリジン誘導体であり、実質的には光学純度が30%e.e.未満のピペリジン誘導体を意味する。
【0025】
本発明のラセミ化は溶媒の無い系でも実施可能であるが、好ましくは不活性な有機溶媒中において実施できる。具体的にはベンゼン、トルエン、キシレン、ヘキサン、オクタン、デカン、シクロヘキサンなどの炭化水素類;メタノール、エタノール、プロパノール、イソプロパノール、ブタノール、イソブタノール、t−ブタノールなどのアルコール類;エチルエーテル、イソプロピルエーテル、ブチルエーテル、イソブチルエーテル、テトラヒドロフラン、ジオキサンなどのエーテル類、あるいはそれらの混合溶媒を反応溶媒に用いることができる。またそれらの溶媒に水を含んでいてもよい。溶媒の使用量は特に制限はないが、経済的な観点から基質に対して50容量倍以内が好ましい。
【0026】
本発明において用いられる還元触媒はニッケル、コバルト、ルテニウム、ロジウム、パラジウム、白金等の周期律表第VIII属の貴金属を含む触媒が好ましく、白金を含むものがさらに好ましい。その形態は特に限定されるものではないがラネーニッケル、ラネーコバルト等のラネー触媒、ルテニウム、ロジウム、パラジウム、白金等を活性炭、アルミナ、あるいはアスベスト等に担持させたものなどが挙げられる。これらの触媒は単独で使用するか、また2種以上の混合物として使用でき、その使用量に制限は無いが、好ましくは光学活性ピペリジン誘導体に対して0.01〜0.5重量倍である。
【0027】
反応は、温度100℃以上が好ましく、さらに好ましくは150℃以上で行われ、使用水素圧は好ましくは0.2MPa以上で行われる。ラセミ化に要する時間は反応温度、水素圧、触媒の種類、あるいは触媒の使用量に関係するが、通常5〜40時間で終了する。
【0028】
目的とするラセミ化されたラセミピペリジン誘導体は、反応終了後、触媒を濾過して取り除いた濾液を濃縮することによって取得できる。
【0029】
かくして得られたラセミピペリジン誘導体はジアステレオマー塩分割の原料として用いることができる。
【0030】
【実施例】
以下、実施例により本発明をさらに詳細に説明するが、本発明はこれに限定するものではない。
【0031】
なお、実施例において得られた3−[3−(メチルスルフォニル)フェニル]−1−プロピルピペリジンの光学純度は、以下の方法で求めた。3−[3−(メチルスルフォニル)フェニル]−1−プロピルピペリジン8〜10mgを25%のエタノールを含むn−ヘキサン溶液10mlに溶解し、その20μlをHPLCに注入して分析した。分析に使用したカラムはChiralpak AS(DAICEL)、移動相はイソヘキサン/メタノール/ジエチルアミン=97.5/2.5/0.1(v/v/v)を用いた。カラム温度は約25℃、流速は0.60ml/minで、検出はUV(267nm)で行った。(R)−3−[3−(メチルスルフォニル)フェニル]−1−プロピルピペリジンは24.5分、(S)−3−[3−(メチルスルフォニル)フェニル]−1−プロピルピペリジンは26.1分に検出した。
【0032】
実施例1
容量100mlのオートクレーブに、(R)−3−[3−(メチルスルフォニル)フェニル]−1−プロピルピペリジン0.49g(光学純度61%e.e.)と5%白金/活性炭(含水品)0.20gおよびエタノール5mlを仕込み、水素圧0.5MPa、温度180℃で21時間反応した。反応終了後、冷却開封し、反応液を濾過して触媒を除いた濾液を濃縮して淡黄色のオイル0.52gを得た。光学純度0%e.e.であり、ラセミ化率100%であった。
【0033】
実施例2
容量100mlのオートクレーブに、(R)−3−[3−(メチルスルフォニル)フェニル]−1−プロピルピペリジン0.53g(光学純度61%e.e.)と5%白金/活性炭(含水品)0.20gおよびエタノール5mlを仕込み、水素圧1.0MPa、温度180℃で21時間反応した。反応終了後、冷却開封し、反応液を濾過して触媒を除いた濾液を濃縮して淡黄色のオイル0.53gを得た。光学純度0%e.e.であり、ラセミ化率100%であった。
【0034】
実施例3
容量100mlのオートクレーブに、(R)−3−[3−(メチルスルフォニル)フェニル]−1−プロピルピペリジン0.50g(光学純度61%e.e.)と5%白金/活性炭(含水品)0.20gおよびn−プロパノール5mlを仕込み、水素圧1.0MPa、温度180℃で18時間反応した。反応終了後、冷却開封し、反応液を濾過して触媒を除いた濾液を濃縮して淡黄色のオイル0.50gを得た。光学純度0%e.e.であり、ラセミ化率100%であった。
【0035】
実施例4
容量500mlのオートクレーブに、(R)−3−[3−(メチルスルフォニル)フェニル]−1−プロピルピペリジン35g(光学純度61%e.e.)と5%白金/活性炭(含水品)14gおよびn−プロパノール350mlを仕込み、水素圧1.0MPa、温度180℃で19時間反応した。反応終了後、冷却開封し、反応液を濾過して触媒を除いた濾液を濃縮して淡黄色のオイル36.5gを得た。光学純度0%e.e.であり、ラセミ化率100%であった。
【0036】
実施例5
容量100mlのオートクレーブに、(R)−3−[3−(メチルスルフォニル)フェニル]−1−プロピルピペリジン0.49g(光学純度61%e.e.)と5%白金/活性炭(含水品)0.20gおよびn−ブタノール5mlを仕込み、水素圧1.0MPa、温度180℃で21時間反応した。反応終了後、冷却開封し、反応液を濾過して触媒を除いた濾液を濃縮して淡黄色のオイル0.52gを得た。光学純度0%e.e.であり、ラセミ化率100%であった。
【0037】
実施例6
容量100mlのオートクレーブに、(R)−3−[3−(メチルスルフォニル)フェニル]−1−プロピルピペリジン0.53g(光学純度61%e.e.)と5%ルテニウム/活性炭(含水品)0.20gおよびエタノール5mlを仕込み、水素圧1.0MPa、温度180℃で21時間反応した。反応終了後、冷却開封し、反応液を濾過して触媒を除いた濾液を濃縮して淡黄色のオイル0.57gを得た。光学純度43%e.e.であり、ラセミ化率30%であった。
【0038】
実施例7
容量100mlのオートクレーブに、(R)−3−[3−(メチルスルフォニル)フェニル]−1−プロピルピペリジン0.52g(光学純度61%e.e.)と5%ロジウム/活性炭(含水品)0.20gおよびエタノール5mlを仕込み、水素圧1.0MPa、温度180℃で21時間反応した。反応終了後、冷却開封し、反応液を濾過して触媒を除いた濾液を濃縮して淡黄色のオイル0.55gを得た。光学純度46%e.e.であり、ラセミ化率25%であった。
【0039】
実施例8
容量100mlのオートクレーブに、(R)−3−[3−(メチルスルフォニル)フェニル]−1−プロピルピペリジン0.53g(光学純度61%e.e.)とラネーニッケル(含水品)0.20gおよびエタノール5mlを仕込み、水素圧1.0MPa、温度180℃で21時間反応した。反応終了後、冷却開封し、反応液を濾過して触媒を除いた濾液を濃縮して淡黄色のオイル0.56gを得た。光学純度58%e.e.であり、ラセミ化率5%であった。
【0040】
実施例9
容量100mlのオートクレーブに、(R)−3−[3−(メチルスルフォニル)フェニル]−1−プロピルピペリジン0.51g(光学純度61%e.e.)と5%白金/活性炭(含水品)0.20gおよびトルエン5mlを仕込み、水素圧1.0MPa、温度150℃で20時間反応した。反応終了後、冷却開封し、反応液を濾過して触媒を除いた濾液を濃縮して淡黄色のオイル0.53gを得た。光学純度57%e.e.であり、ラセミ化率7%であった。
【0041】
実施例10
容量100mlのオートクレーブに、(R)−3−[3−(メチルスルフォニル)フェニル]−1−プロピルピペリジン0.51g(光学純度61%e.e.)と5%白金/活性炭(含水品)0.20gおよびイソプロピルエーテル5mlを仕込み、水素圧1.0MPa、温度150℃で20時間反応した。反応終了後、冷却開封し、反応液を濾過して触媒を除いた濾液を濃縮して淡黄色のオイル0.54gを得た。光学純度55e.e.であり、ラセミ化率10%であった。
【0042】
実施例11
容量100mlのオートクレーブに、(R)−3−[3−(メチルスルフォニル)フェニル]−1−プロピルピペリジン3.7g(光学純度50%e.e.)と5%白金/活性炭(含水品)1.6gおよびエタノール40mlを仕込み、水素圧1.0MPa、温度180℃で18時間反応した。反応終了後、冷却開封し、反応液を濾過して触媒を除いた濾液を濃縮して淡黄色のオイル4.0gを得た。光学純度0%e.e.であり、ラセミ化率100%であった。
【0043】
【発明の効果】
本発明によれば、ラセミピペリジン誘導体が効率よく、工業的に実施可能な方法で得られる。[0001]
BACKGROUND OF THE INVENTION
The present invention is a general formula (1), general formula (2), general formula (3) useful as a pharmaceutical or an intermediate thereof.
[0002]
[Formula 4]
Figure 0004904517
[0003]
(R 1 represents a lower alkyl group having 1 to 4 carbon atoms, a phenyl group, and an aralkyl group, and R 2 , R 3 , and R 4 may be the same or different, hydrogen, alkyl group, phenyl group , An aralkyl group, an alkoxycarbonyl group, an alkylsulfonyl group, an allylsulfonyl group, an aralkylsulfonyl group, and an acyl group, R 5 represents an alkyl group, a phenyl group, an aralkyl group, an alkoxycarbonyl group, an alkylsulfonyl group, an allylsulfonyl group, A method for producing a racemic piperidine derivative by racemizing an unnecessary optical enantiomer produced as a by-product when the optically active piperidine derivative represented by aralkylsulfonyl group and acyl group is produced by optical resolution. Is to provide. In particular, formula (6)
[0004]
[Chemical formula 5]
Figure 0004904517
[0005]
An optically active 3- [3- (methylsulfonyl) phenyl] -1-propylpiperidine represented by the formula is a useful compound as a Parkinson's disease drug.
[0006]
[Prior art]
In order to obtain an optically active piperidine derivative, the racemic form may be optically resolved, but the yield is theoretically 50% of the racemic form, which is insufficient as an industrial production method. Therefore, if an unnecessary optical enantiomer can be racemized and recycled as a raw material for optical resolution, an optically active piperidine derivative can theoretically be produced in a yield close to 100%. Therefore, it can be said that a method for producing a racemic piperidine derivative by racemizing an optically active piperidine derivative is an important technique. However, general formula (1), general formula (2), general formula (3)
[0007]
[Chemical 6]
Figure 0004904517
[0008]
(R 1 represents a lower alkyl group having 1 to 4 carbon atoms, a phenyl group, and an aralkyl group, and R 2 , R 3 , and R 4 may be the same or different, hydrogen, alkyl group, phenyl group , An aralkyl group, an alkoxycarbonyl group, an alkylsulfonyl group, an allylsulfonyl group, an aralkylsulfonyl group, and an acyl group, R 5 represents an alkyl group, a phenyl group, an aralkyl group, an alkoxycarbonyl group, an alkylsulfonyl group, an allylsulfonyl group, A method for racemizing an optically active piperidine derivative represented by aralkylsulfonyl group and acyl group) is not known at all.
[0009]
[Problems to be solved by the invention]
As described above, when the racemic piperidine derivative is optically resolved to produce a desired optically active piperidine derivative, another unnecessary optical enantiomer is generated. Therefore, in order to produce a desired optically active piperidine derivative with high yield, a method for racemizing the optically active piperidine derivative has been desired.
[0010]
[Means for Solving the Problems]
As a result of intensive studies on an industrially feasible production method for racemic piperidine derivatives, the present inventors have found that this object can be achieved by reacting an optically active piperidine derivative in the presence of a reduction catalyst under hydrogen pressure. It was.
[0011]
That is, the present invention relates to general formula (1), general formula (2), general formula (3).
[0012]
[Chemical 7]
Figure 0004904517
[0013]
(R 1 represents a lower alkyl group having 1 to 4 carbon atoms, a phenyl group, and an aralkyl group, and R 2 , R 3 , and R 4 may be the same or different, hydrogen, alkyl group, phenyl group , An aralkyl group, an alkoxycarbonyl group, an alkylsulfonyl group, an allylsulfonyl group, an aralkylsulfonyl group, and an acyl group, R 5 represents an alkyl group, a phenyl group, an aralkyl group, an alkoxycarbonyl group, an alkylsulfonyl group, an allylsulfonyl group, An aralkylsulfonyl group and an acyl group are shown.)
A method for producing a racemic piperidine derivative, comprising reacting an optically active piperidine derivative represented by any of the above in a hydrogen atmosphere in the presence of a reduction catalyst.
[0014]
DETAILED DESCRIPTION OF THE INVENTION
Here, optically active piperidine derivatives used as starting materials in the present invention include the following general formula (1), general formula (2), and general formula (3).
[0015]
[Chemical 8]
Figure 0004904517
[0016]
(R 1 represents a lower alkyl group having 1 to 4 carbon atoms, a phenyl group, and an aralkyl group, and R 2 , R 3 , and R 4 may be the same or different, hydrogen, alkyl group, phenyl group , An aralkyl group, an alkoxycarbonyl group, an alkylsulfonyl group, an allylsulfonyl group, an aralkylsulfonyl group, and an acyl group, R 5 represents an alkyl group, a phenyl group, an aralkyl group, an alkoxycarbonyl group, an alkylsulfonyl group, an allylsulfonyl group, An optically active piperidine derivative represented by any one of aralkylsulfonyl group and acyl group) can be used. Especially, it can apply preferably, when racemizing the optically active piperidine derivative represented by General formula (1).
[0017]
Further, the optically active piperidine derivative is represented by the formula (4) or (5):
[0018]
[Chemical 9]
Figure 0004904517
[0019]
(R 1 represents a lower alkyl group having 1 to 4 carbon atoms, and R 4 represents an alkylsulfonyl group having 1 to 4 carbon atoms.)
It can be preferably applied when it is shown by.
[0020]
In particular, formula (6)
[0021]
[Chemical Formula 10]
Figure 0004904517
[0022]
It is useful in producing racemic 3- [3- (methylsulfonyl) phenyl] -1-propylpiperidine represented by the formula:
[0023]
Here, the optically active piperidine derivative means a piperidine derivative containing one optical isomer more than the other optical isomer, and substantially has an optical purity of 30% e.e. e. The above piperidine derivatives are meant.
[0024]
The racemic piperidine derivative is a piperidine derivative having a lower optical purity than the raw material, and the optical purity is substantially 30% e.e. e. Means less piperidine derivatives.
[0025]
The racemization of the present invention can be carried out in a solvent-free system but is preferably carried out in an inert organic solvent. Specifically, hydrocarbons such as benzene, toluene, xylene, hexane, octane, decane, cyclohexane; alcohols such as methanol, ethanol, propanol, isopropanol, butanol, isobutanol, and t-butanol; ethyl ether, isopropyl ether, Ethers such as butyl ether, isobutyl ether, tetrahydrofuran and dioxane, or a mixed solvent thereof can be used as a reaction solvent. Further, these solvents may contain water. The amount of the solvent used is not particularly limited, but is preferably within 50 times the volume of the substrate from the economical viewpoint.
[0026]
The reduction catalyst used in the present invention is preferably a catalyst containing a noble metal belonging to Group VIII of the periodic table such as nickel, cobalt, ruthenium, rhodium, palladium, platinum, and more preferably one containing platinum. The form is not particularly limited, and examples thereof include Raney catalysts such as Raney nickel and Raney cobalt, ruthenium, rhodium, palladium, platinum and the like supported on activated carbon, alumina, asbestos and the like. These catalysts can be used singly or as a mixture of two or more, and the amount used is not limited, but is preferably 0.01 to 0.5 times by weight based on the optically active piperidine derivative.
[0027]
The reaction is preferably performed at a temperature of 100 ° C. or higher, more preferably 150 ° C. or higher, and the hydrogen pressure used is preferably 0.2 MPa or higher. The time required for racemization is related to the reaction temperature, hydrogen pressure, catalyst type, or amount of catalyst used, but it usually ends in 5 to 40 hours.
[0028]
The target racemic racemic piperidine derivative can be obtained by concentrating the filtrate after removing the catalyst by filtration after the reaction is completed.
[0029]
The racemic piperidine derivative thus obtained can be used as a raw material for diastereomeric salt resolution.
[0030]
【Example】
EXAMPLES Hereinafter, although an Example demonstrates this invention further in detail, this invention is not limited to this.
[0031]
The optical purity of 3- [3- (methylsulfonyl) phenyl] -1-propylpiperidine obtained in the examples was determined by the following method. 8 to 10 mg of 3- [3- (methylsulfonyl) phenyl] -1-propylpiperidine was dissolved in 10 ml of n-hexane solution containing 25% ethanol, and 20 μl thereof was injected into HPLC for analysis. The column used for the analysis was Chiralpak AS (DAICEL), and the mobile phase was isohexane / methanol / diethylamine = 97.5 / 2.5 / 0.1 (v / v / v). The column temperature was about 25 ° C., the flow rate was 0.60 ml / min, and detection was performed with UV (267 nm). (R) -3- [3- (methylsulfonyl) phenyl] -1-propylpiperidine is 24.5 minutes, and (S) -3- [3- (methylsulfonyl) phenyl] -1-propylpiperidine is 26.1 minutes. Detected in minutes.
[0032]
Example 1
In a 100 ml autoclave, 0.49 g (R) -3- [3- (methylsulfonyl) phenyl] -1-propylpiperidine (optical purity 61% ee) and 5% platinum / activated carbon (water-containing product) 0 20 g and 5 ml of ethanol were charged and reacted at a hydrogen pressure of 0.5 MPa and a temperature of 180 ° C. for 21 hours. After completion of the reaction, the reaction mixture was unsealed and the reaction solution was filtered to remove the catalyst, and the filtrate was concentrated to obtain 0.52 g of a pale yellow oil. Optical purity 0% e.e. e. The racemization rate was 100%.
[0033]
Example 2
In a 100 ml autoclave, 0.53 g (R) -3- [3- (methylsulfonyl) phenyl] -1-propylpiperidine (optical purity 61% ee) and 5% platinum / activated carbon (water-containing product) 0 .20 g and 5 ml of ethanol were charged and reacted at a hydrogen pressure of 1.0 MPa and a temperature of 180 ° C. for 21 hours. After completion of the reaction, the reaction mixture was unsealed and the reaction solution was filtered to remove the catalyst, and the filtrate was concentrated to obtain 0.53 g of a pale yellow oil. Optical purity 0% e.e. e. The racemization rate was 100%.
[0034]
Example 3
In a 100 ml autoclave, 0.50 g (R) -3- [3- (methylsulfonyl) phenyl] -1-propylpiperidine (optical purity 61% ee) and 5% platinum / activated carbon (water-containing product) 0 20 g and 5 ml of n-propanol were charged and reacted at a hydrogen pressure of 1.0 MPa and a temperature of 180 ° C. for 18 hours. After completion of the reaction, the reaction mixture was unsealed and the reaction solution was filtered to remove the catalyst, and the filtrate was concentrated to obtain 0.50 g of a pale yellow oil. Optical purity 0% e.e. e. The racemization rate was 100%.
[0035]
Example 4
In an autoclave with a capacity of 500 ml, 35 g of (R) -3- [3- (methylsulfonyl) phenyl] -1-propylpiperidine (optical purity 61% ee), 14 g of 5% platinum / activated carbon (water-containing product) and n -350 ml of propanol was charged and reacted at a hydrogen pressure of 1.0 MPa and a temperature of 180 ° C. for 19 hours. After completion of the reaction, the reaction mixture was unsealed and the reaction solution was filtered to remove the catalyst, and the filtrate was concentrated to obtain 36.5 g of a pale yellow oil. Optical purity 0% e.e. e. The racemization rate was 100%.
[0036]
Example 5
In a 100 ml autoclave, 0.49 g (R) -3- [3- (methylsulfonyl) phenyl] -1-propylpiperidine (optical purity 61% ee) and 5% platinum / activated carbon (water-containing product) 0 20 g and 5 ml of n-butanol were charged and reacted at a hydrogen pressure of 1.0 MPa and a temperature of 180 ° C. for 21 hours. After completion of the reaction, the reaction mixture was unsealed and the reaction solution was filtered to remove the catalyst, and the filtrate was concentrated to obtain 0.52 g of a pale yellow oil. Optical purity 0% e.e. e. The racemization rate was 100%.
[0037]
Example 6
In a 100 ml autoclave, 0.53 g (R) -3- [3- (methylsulfonyl) phenyl] -1-propylpiperidine (optical purity 61% ee) and 5% ruthenium / activated carbon (water-containing product) 0 .20 g and 5 ml of ethanol were charged and reacted at a hydrogen pressure of 1.0 MPa and a temperature of 180 ° C. for 21 hours. After completion of the reaction, the reaction mixture was unsealed and the reaction solution was filtered to remove the catalyst, and the filtrate was concentrated to obtain 0.57 g of a pale yellow oil. Optical purity 43% e.e. e. The racemization rate was 30%.
[0038]
Example 7
In a 100 ml autoclave, 0.52 g (R) -3- [3- (methylsulfonyl) phenyl] -1-propylpiperidine (optical purity 61% ee) and 5% rhodium / activated carbon (water-containing product) 0 .20 g and 5 ml of ethanol were charged and reacted at a hydrogen pressure of 1.0 MPa and a temperature of 180 ° C. for 21 hours. After completion of the reaction, the reaction mixture was unsealed and the reaction solution was filtered to remove the catalyst, and the filtrate was concentrated to obtain 0.55 g of a pale yellow oil. Optical purity 46% e.e. e. The racemization rate was 25%.
[0039]
Example 8
In a 100 ml autoclave, 0.53 g (R) -3- [3- (methylsulfonyl) phenyl] -1-propylpiperidine (optical purity 61% ee), Raney nickel (water-containing product) 0.20 g and ethanol 5 ml was charged and reacted at a hydrogen pressure of 1.0 MPa and a temperature of 180 ° C. for 21 hours. After completion of the reaction, the reaction mixture was unsealed and the reaction solution was filtered to remove the catalyst, and the filtrate was concentrated to obtain 0.56 g of a pale yellow oil. Optical purity 58% e.e. e. The racemization rate was 5%.
[0040]
Example 9
In a 100 ml autoclave, 0.51 g (R) -3- [3- (methylsulfonyl) phenyl] -1-propylpiperidine (optical purity 61% ee) and 5% platinum / activated carbon (water-containing product) 0 .20 g and 5 ml of toluene were charged and reacted at a hydrogen pressure of 1.0 MPa and a temperature of 150 ° C. for 20 hours. After completion of the reaction, the reaction mixture was unsealed and the reaction solution was filtered to remove the catalyst, and the filtrate was concentrated to obtain 0.53 g of a pale yellow oil. Optical purity 57% e.e. e. The racemization rate was 7%.
[0041]
Example 10
In a 100 ml autoclave, 0.51 g (R) -3- [3- (methylsulfonyl) phenyl] -1-propylpiperidine (optical purity 61% ee) and 5% platinum / activated carbon (water-containing product) 0 20 g and 5 ml of isopropyl ether were charged and reacted at a hydrogen pressure of 1.0 MPa and a temperature of 150 ° C. for 20 hours. After completion of the reaction, the reaction mixture was unsealed and the reaction solution was filtered to remove the catalyst, and the filtrate was concentrated to obtain 0.54 g of a pale yellow oil. Optical purity 55e. e. The racemization rate was 10%.
[0042]
Example 11
In an autoclave with a capacity of 100 ml, 3.7 g of (R) -3- [3- (methylsulfonyl) phenyl] -1-propylpiperidine (optical purity 50% ee) and 5% platinum / activated carbon (water-containing product) 1 .6 g and 40 ml of ethanol were charged and reacted at a hydrogen pressure of 1.0 MPa and a temperature of 180 ° C. for 18 hours. After completion of the reaction, the reaction mixture was unsealed and the reaction solution was filtered to remove the catalyst, and the filtrate was concentrated to obtain 4.0 g of a pale yellow oil. Optical purity 0% e.e. e. The racemization rate was 100%.
[0043]
【Effect of the invention】
According to the present invention, a racemic piperidine derivative can be obtained in an efficient and industrially feasible manner.

Claims (6)

一般式(1)、一般式(2)、一般式(3)
Figure 0004904517
(R1は炭素数1〜4の低級アルキル基、フェニル基、およびアラルキル基を示し、R2、R3、R4は同じであっても異なっていてもよく、水素、アルキル基、フェニル基、アラルキル基、アルコキシカルボニル基、アルキルスルホニル基、アリルスルホニル基、アラルキルスルホニル基、およびアシル基を示し、R5はアルキル基、フェニル基、アラルキル基、アルコキシカルボニル基、アルキルスルホニル基、アリルスルホニル基、アラルキルスルホニル基、およびアシル基を示す。)
のいずれかで表される光学活性ピペリジン誘導体を、還元触媒存在下に水素雰囲気中で反応させることを特徴とするラセミピペリジン誘導体の製造方法。
General formula (1), general formula (2), general formula (3)
Figure 0004904517
(R 1 represents a lower alkyl group having 1 to 4 carbon atoms, a phenyl group, and an aralkyl group, and R 2 , R 3 , and R 4 may be the same or different, hydrogen, alkyl group, phenyl group , An aralkyl group, an alkoxycarbonyl group, an alkylsulfonyl group, an allylsulfonyl group, an aralkylsulfonyl group, and an acyl group, R 5 represents an alkyl group, a phenyl group, an aralkyl group, an alkoxycarbonyl group, an alkylsulfonyl group, an allylsulfonyl group, An aralkylsulfonyl group and an acyl group are shown.)
A process for producing a racemic piperidine derivative, comprising reacting an optically active piperidine derivative represented by any of the above in a hydrogen atmosphere in the presence of a reduction catalyst.
還元触媒が周期律表第VIII属の金属を含むものであることを特徴とする請求項1記載のラセミピペリジン誘導体の製造方法。The method for producing a racemic piperidine derivative according to claim 1, wherein the reduction catalyst contains a metal of Group VIII of the Periodic Table. 周期律表第VIII属の金属が白金であることを特徴とする請求項2記載のラセミピペリジン誘導体の製造方法。The method for producing a racemic piperidine derivative according to claim 2, wherein the metal of Group VIII of the Periodic Table is platinum. 水素雰囲気が0.2MPa以上の加圧系であることを特徴とする請求項1〜3のいずれか1項記載のラセミピペリジン誘導体の製造方法。The method for producing a racemic piperidine derivative according to any one of claims 1 to 3, wherein the hydrogen atmosphere is a pressurized system of 0.2 MPa or more. 光学活性ピペリジン誘導体が式(4)または(5)
Figure 0004904517
(R1は炭素数1〜4の低級アルキル基、R4は炭素数1〜4のアルキルスルホニル基を示す。)
で示されるものであることを特徴とする請求項1〜4のいずれか1項記載のラセミピペリジン誘導体の製造方法。
The optically active piperidine derivative is represented by the formula (4) or (5)
Figure 0004904517
(R 1 represents a lower alkyl group having 1 to 4 carbon atoms, and R 4 represents an alkylsulfonyl group having 1 to 4 carbon atoms.)
It is shown by these, The manufacturing method of the racemic piperidine derivative of any one of Claims 1-4 characterized by the above-mentioned.
光学活性ピペリジン誘導体が式(6)
Figure 0004904517
で表される光学活性3−[3−(メチルスルフォニル)フェニル]−1−プロピルピペリジンであることを特徴とする請求項1〜5のいずれか1項記載のラセミピペリジン誘導体の製造方法。
The optically active piperidine derivative has the formula (6)
Figure 0004904517
The method for producing a racemic piperidine derivative according to claim 1, wherein the optically active 3- [3- (methylsulfonyl) phenyl] -1-propylpiperidine represented by the formula:
JP2001279111A 2000-09-18 2001-09-14 Method for producing racemic piperidine derivatives Expired - Lifetime JP4904517B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001279111A JP4904517B2 (en) 2000-09-18 2001-09-14 Method for producing racemic piperidine derivatives

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2000-282512 2000-09-18
JP2000282512 2000-09-18
JP2000282512 2000-09-18
JP2001279111A JP4904517B2 (en) 2000-09-18 2001-09-14 Method for producing racemic piperidine derivatives

Publications (2)

Publication Number Publication Date
JP2002234873A JP2002234873A (en) 2002-08-23
JP4904517B2 true JP4904517B2 (en) 2012-03-28

Family

ID=26600157

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001279111A Expired - Lifetime JP4904517B2 (en) 2000-09-18 2001-09-14 Method for producing racemic piperidine derivatives

Country Status (1)

Country Link
JP (1) JP4904517B2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0717610B2 (en) * 1986-02-14 1995-03-01 川研ファインケミカル株式会社 <1> -Method for racemizing octahydroisoquinoline derivative
JP3021109B2 (en) * 1991-05-17 2000-03-15 第一製薬株式会社 Preparation of amino compounds

Also Published As

Publication number Publication date
JP2002234873A (en) 2002-08-23

Similar Documents

Publication Publication Date Title
US6962998B2 (en) Processes for producing racemic piperidine derivative and for producing optically active piperidine derivative
JP5663176B2 (en) Process for producing chiral beta amino acid derivatives by asymmetric hydrogenation
CN102177170B (en) Novel ruthenium carbonyl complex having a tridentate ligand and manufacturing method and usage thereof
US20090192326A1 (en) Preparation of sitagliptin intermediate
JP2008528503A (en) Method to chiral beta amino acid derivatives by asymmetric hydrogenation
US8222452B2 (en) Method for producing optically active amines
CN101511786A (en) Process for the preparation of levetiracetam
US6492544B2 (en) Process for synthesis of enantiomerically enriched β-amino acids
JP6917949B2 (en) An improved method for the preparation of chiral 3-amino-piperidine, a useful intermediate for the preparation of tofacitinib
JP5899204B2 (en) Process for producing chiral β-aminocarboxamide derivative
JP3598277B2 (en) Method for producing ethanesulfonylpiperidine derivative
JP4904517B2 (en) Method for producing racemic piperidine derivatives
CN113072486B (en) Amino alcohol-boron-binaphthol complex and preparation method of optically active amino alcohol derivative using same
CN115028569B (en) Indoline-2-ketone-3-acetamide series compound and preparation method thereof
JP2011012032A (en) Method for producing optically active 3-aminopiperidine and production intermediate
EP3016961B1 (en) Novel ruthenium catalysts and their use for asymmetric reduction of ketones
KR101446017B1 (en) Method for the stereoselective preparation of 4-alkyl-5-aryl 5-membered ring sulfamidates
CN1989097A (en) Process for the preparation of a diastereomerically enriched compound
JP2009023978A (en) Method for producing trans-2-benzyloxycyclohexylamine
US20090203918A1 (en) Method for producing enantiomeric form of 2,3-diaminopropionic acid derivatives
JP4143745B2 (en) Process for producing optically active α-methylbenzylamine
WO2006030017A1 (en) Synthesis of amine stereoisomers
JP4339074B2 (en) Process for producing optically active 1,2-bis (3,5-dimethylphenyl) -1,2-ethanediamine
US7659424B2 (en) Process for the allylation of n-acylhydrazones
TWI308912B (en) Process for preparing 2-oxo-1-pyrrolidine derivatives

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20080901

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080902

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20080901

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20111213

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20111219

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150120

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4904517

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term